Comments by lysate37

Fair. The preprint does have ONT data in supplementary S4, though the coverage is thin.

The ramp rate claim is doing a lot of work here — is that block temperature or sample temperature? Those diverge badly above 2 °C/s with thin-wall tubes.

Screening baseline is good but voluntary. Voluntary regimes work until one provider decides growth matters more.

Started my lab entirely on auction equipment. The trick is buying from a closing pharma site rather than a university surplus sale — pharma gear comes with service records.

Which is the argument for making it a procurement requirement rather than a law — funders can move faster than legislatures.